Showing results (311-320 of 461) with videos related to

Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implicationsPeter Birner, Matthias Preusser, Ellen Gelpi, et al.
Proteomics|June 2, 2006
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinomaRachel A Craven, Sarah Hanrahan, Nick Totty, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2003
Breast cancer classification and prognosis based on gene expression profiles from a population-based studyChristos Sotiriou, Soek-Ying Neo, Lisa M McShane, et al.
The Journal of Urology|June 19, 2007
An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancerJonathan J Ord, Sachin Agrawal, Thomas P Thamboo, et al.
Plos One|July 9, 2011
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancerFrançoise Rothé, Michail Ignatiadis, Carole Chaboteaux, et al.
Angiogenesis|August 21, 2013
The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identityBushra Gorsi, Feng Liu, Xing Ma, et al.
Frontiers in Chemistry|July 6, 2018
A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of AngiogenesisCharalampos Tsoukalas, Dimitrios Psimadas, George A Kastis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid TumorsElena Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapyMichael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, et al.
Ebiomedicine|July 31, 2016
Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic TreatmentShaveta Mehta, Nick P Hughes, Sonia Li, et al.
Pageof 47